We are live on ! Find out more
BNR

Burning Rock Biotech

85 hedge funds and large institutions have $794M invested in Burning Rock Biotech in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 9

57% more funds holding

Funds holding: 5485 (+31)

25% more capital invested

Capital invested by funds: $635M → $794M (+$159M)

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

0.39% more ownership

Funds ownership: 2.7%3.09% (+0.39%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
85
Holders Change
+31
Holders Change %
+57.41%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
40
Increased
19
Reduced
16
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AP
51
AtonRa Partners
Switzerland
$1.04M -$6.21K -21 -0.6%
Bank of New York Mellon
52
Bank of New York Mellon
New York
$1.04M +$1.04M +3,531 New
BA
53
Bridgewater Associates
Connecticut
$1M +$1M +3,396 New
CIP
54
Champlain Investment Partners
Vermont
$887K +$891K +3,010 New
RI
55
RTW Investments
New York
$884K
AAF
56
Andra AP-fonden
Sweden
$866K +$870K +2,940 New
Axa
57
Axa
France
$795K
KFA
58
Krane Funds Advisors
New York
$778K +$781K +2,641 New
DekaBank Deutsche Girozentrale
59
DekaBank Deutsche Girozentrale
Germany
$772K +$83.7K +283 New
Invesco
60
Invesco
Georgia
$746K +$101K +341 +16%
Jane Street
61
Jane Street
New York
$615K +$617K +2,087 New
BCIM
62
British Columbia Investment Management
British Columbia, Canada
$536K +$538K +1,820 New
PCM
63
Prelude Capital Management
New York
$388K +$19.5K +66 +5%
Mitsubishi UFJ Trust & Banking
64
Mitsubishi UFJ Trust & Banking
Japan
$387K +$388K +1,313 New
CSS
65
Cubist Systematic Strategies
Connecticut
$317K +$319K +1,078 New
Mitsubishi UFJ Asset Management
66
Mitsubishi UFJ Asset Management
Japan
$309K +$311K +1,050 New
VIA
67
Vident Investment Advisory
Georgia
$249K
Qube Research & Technologies (QRT)
68
Qube Research & Technologies (QRT)
United Kingdom
$230K -$67.5K -228 -23%
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$215K +$216K +730 New
Caisse de Depot et Placement du Quebec (CDPQ)
70
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$206K +$207K +700 New
Zurich Cantonal Bank
71
Zurich Cantonal Bank
Switzerland
$200K +$200K +677 New
SAM
72
Shell Asset Management
Netherlands
$130K +$130K +440 New
Asset Management One
73
Asset Management One
Japan
$125K +$126K +427 New
Macquarie Group
74
Macquarie Group
Australia
$95K +$95.3K +322 New
Ensign Peak Advisors
75
Ensign Peak Advisors
Utah
$90K +$90.2K +305 New

BNR Hedge Fund Activity: Q2 2021 in Review

85 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q2 2021, worth a combined $794M — up 25% from $635M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new BNR positions and 9 closed out — a net gain of 31 holders — while 19 added to existing stakes and 16 trimmed.

The largest buyer was Baillie Gifford & Co, adding an estimated $55.6M. The largest seller was Casdin Capital, exiting entirely with an estimated $22.8M sold.

  • 85 institutional investors held Burning Rock Biotech (BNR) as of Q2 2021, up from 54 in Q1 2021.
  • Funds reported $794M of Burning Rock Biotech stock for Q2 2021, up 25% quarter-over-quarter.
  • 40 funds opened new Burning Rock Biotech positions in Q2 2021 and 9 closed out, a net change of +31 holders.
  • The largest Burning Rock Biotech buyer in Q2 2021 was Baillie Gifford & Co, an estimated $55.6M added.
  • The largest Burning Rock Biotech seller in Q2 2021 was Casdin Capital, an estimated $22.8M sold.

Based on aggregated 13F filings for Q2 2021.